当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 现金流量表

尔康制药

(300267)

  

流通市值:48.79亿  总市值:70.75亿
流通股本:14.22亿   总股本:20.63亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金792,973,373.15335,403,374.851,062,706,428.64854,076,763.42
  收到的税费返还6,302,693.65,572,527.3925,874,581.7923,609,449.57
  收到其他与经营活动有关的现金6,472,954.013,214,667.87163,674,063.4974,404,389.5
  经营活动现金流入小计805,749,020.76344,190,570.111,252,255,073.92952,090,602.49
  购买商品、接受劳务支付的现金584,585,381.69277,036,053.2589,418,175.86438,224,548.78
  支付给职工以及为职工支付的现金83,903,371.5447,599,108.83165,014,824.22126,148,792.36
  支付的各项税费24,868,076.8112,289,296.1769,192,077.7350,339,085.75
  支付其他与经营活动有关的现金66,549,943.1911,414,618.81261,938,289.19261,563,935.38
  经营活动现金流出小计759,906,773.23348,339,077.011,085,563,367876,276,362.27
  经营活动产生的现金流量净额45,842,247.53-4,148,506.9166,691,706.9275,814,240.22
二、投资活动产生的现金流量:
  收回投资收到的现金340,000,000100,000,000210,434,000210,434,000
  取得投资收益收到的现金2,898,851.972,668,013.71,899,061.741,899,061.74
  处置固定资产、无形资产和其他长期资产收回的现金净额1,167,927.99340,319.1181,300181,300
  收到的其他与投资活动有关的现金---705,000
  投资活动现金流入小计344,066,779.96103,008,332.8212,514,361.74213,219,361.74
  购建固定资产、无形资产和其他长期资产支付的现金54,007,926.1929,637,797.69195,599,337.8164,305,107.01
  投资支付的现金395,000,000-330,202,000310,202,000
  支付其他与投资活动有关的现金--8,868,000-
  投资活动现金流出小计449,007,926.1929,637,797.69534,669,337.8474,507,107.01
  投资活动产生的现金流量净额-104,941,146.2373,370,535.11-322,154,976.06-261,287,745.27
三、筹资活动产生的现金流量:
  取得借款收到的现金220,000,000120,000,000546,080,000307,700,000
  收到其他与筹资活动有关的现金190,000,00050,000,000250,000,000200,000,000
  筹资活动现金流入小计410,000,000170,000,000796,080,000507,700,000
  偿还债务支付的现金387,700,000197,700,000401,000,000259,000,000
  分配股利、利润或偿付利息支付的现金5,542,786.082,563,375.018,415,180.447,323,231.55
  支付其他与筹资活动有关的现金82,672,626.1330,291,022.69245,520,414.9103,203,261.39
  筹资活动现金流出小计475,915,412.21230,554,397.7654,935,595.34369,526,492.94
  筹资活动产生的现金流量净额-65,915,412.21-60,554,397.7141,144,404.66138,173,507.06
四、汇率变动对现金及现金等价物的影响-1,555,462.31-1,106,513.25-6,409,837.1-9,550,453.85
五、现金及现金等价物净增加额-126,569,773.227,561,117.26-20,728,701.58-56,850,451.84
  加:期初现金及现金等价物余额489,909,024.78489,909,024.78510,637,726.36510,637,726.36
  期末现金及现金等价物余额363,339,251.56497,470,142.04489,909,024.78453,787,274.52
补充资料:
  净利润28,810,557.54--392,626,872.67-
  资产减值准备-1,908,417.18-261,135,938.67-
  固定资产和投资性房地产折旧76,223,717.64-168,736,391.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧76,223,717.64-168,736,391.72-
  无形资产摊销11,025,411.4-22,764,864.25-
  长期待摊费用摊销1,700,062.25-3,454,583.57-
  处置固定资产、无形资产和其他长期资产的损失-323,099.98--198,252.71-
  固定资产报废损失251,262.87---
  公允价值变动损失2,979,757.81--419,800-
  财务费用6,158,392.89-15,740,953.25-
  投资损失-2,896,732.49-55,457,681.43-
  递延所得税1,451,124.61-2,290,798.66-
  其中:递延所得税资产减少1,926,820.89-1,591,118.99-
    递延所得税负债增加-475,696.28-699,679.67-
  存货的减少-26,109,504.88-66,643,804.28-
  经营性应收项目的减少-27,668,358.72--21,891,982.92-
  经营性应付项目的增加2,727,597.77--35,606,779.41-
  其他-30,258,886.21-15,353,763.85-
  现金的期末余额363,339,251.56-489,909,024.78-
  减:现金的期初余额489,909,024.78-510,637,726.36-
  现金及现金等价物的净增加额-126,569,773.22--20,728,701.58-
公告日期2025-08-282025-04-232025-04-232024-10-25
审计意见(境内)标准无保留意见
TOP↑